Life Sciences CIO Roundtable

March 29, 2018 @ 5:30 pm – 8:30 pm
SAGE Therapeutics
215 First St
Cambridge, MA 02142
$0 for eligible members and invited guests - hosted by SAGE Therapeutics
Jennifer Lynch

SIM Boston Life Sciences CIO Roundtable

Date:  Thursday, March 29, 2018 from 5:30pm – 8:00pm

Location:  Hosted by SAGE Therapeutics, 215 First Street, Cambridge, MA  02142

Agenda:  5:30pm Registration/Networking;  6:00pm Dinner/Presentations

Registration Costs:  FREE to local Life Sciences CIOs and approved colleagues

Topic:  Impact of Blockchain and GDPR (EU Privacy Regulation) within the Life Sciences Industry

Speakers:  Maria Palombini and Mark Steinhoff

Register Today!

Blockchain adoption within the Pharmaceutical Supply Chain is moving faster than you think. IEEE Standards Association (IEEE-SA) commissioned a one-of-a-kind independent research study to examine the State of Blockchain Adoption on the Pharmaceutical Supply Chain. Maria Palombini of IEEE-SA will give an update on the report offering detailed insights on unresolved financial, regulator, policy, and protocol issues while unraveling the expectations and commitments of partners when participating on a blockchain-driven pharmaceutical supply chain.

The deadline for compliance with the EU’s General Data Protection Regulation (GDPR) is set for May 25, 2018.  The regulation may require substantial changes to the ways in which your organization handles personal information of EU residents. Failure to address the GDPR’s requirements are significant and could result in fines of up to 4% of worldwide turnover.  Mark Steinhoff of Deloitte will discuss the pending requirements and final steps you should take in the countdown to May 2018 and answer questions to help you assess your organizations preparedness and exposure for GDPR.

MARIA PALOMBINI, MBA, Director, Emerging Communities & Initiatives Development, Global Business Strategy & Intelligence, IEEE Standards Association

Maria is the creator, leader and advocate for the Pharma Blockchain Initiative, which seeks to bring awareness and balanced learning to the pharmaceutical community and its key stakeholders on the viable applications of blockchain within the pharmaceutical framework. The goal of the initiative is advance adoption of blockchain in combination with emerging technologies (ie. AI, IoT, etc) where it will lead to enhanced patient safety and care, and optimize and innovate drug development.

In 2017, Maria joined IEEE-SA with a directive to build communities and advance initiatives to develop standards for enterprise adoption of emerging technologies. Her work includes building communities of technologists, industry executives, academic researchers and industry stakeholders to educate on the benefits and challenges of viable applications of emerging technologies, while building consensus on recommendations for frameworks on technical standards and recommended guidelines for protocol and policies to enhance the outcomes of technology implementation. Her primary areas of focus include the pharma, health, supply chain, energy, and agriculture sectors. In parallel to her work in blockchain standards, she is the project lead for IEEE-SA’s newest initiative, Digital Inclusion through Trust and Agency, a critical program focused on bringing the outstanding 50% of the world’s population online while working with technologists, advocacy groups and policy leaders on developing trusted frameworks that will protect the digital persona, the right to be forgotten, and restoring dignity to digital transactions for ALL members of the global community.

Maria currently holds an MBA from the Rutgers Graduate School of Business and a BA and BS from Rutgers College at Rutgers University, the State University of New Jersey. She is an accomplished leader and public speaker having presented at various industry events. You can follow her on twitter @DisruptiveRx or on

MARK STEINHOFF, Managing Director, Deloitte & Touche LLP

Mark is a Managing Director in our Privacy and Data Protection practice.  Mark has served a variety of clients across industries in areas ranging from privacy program assessments and benchmark analyses, to developing and implementing broad privacy and data protection programs. Mark’s experience also includes assisting clients with issues related to a range of U.S. and global privacy and data protection laws and regulations, most recently with the European Union General Data Protection Regulation, with an emphasis on program development, regulatory compliance, and operational implementation. He also advises clients on leading practices and requirements in order to safeguard corporate assets, including confidential data, intellectual property, and sensitive data, such as credit card and protected health information, as well as evaluation of third-party service providers and incident response preparedness and handling.

Mark has over 30 years of combined experience across a range of privacy and security disciplines, as well as experience with enterprise risk management, governance, risk and compliance management, and systems project implementations. Prior to joining Deloitte & Touche, Mark spent 13 years in a variety of roles including information security administration, program management and information technology audit. Mark is also a Certified Information Privacy Professional (CIPP).

Register Today!

Leave a Comment